BARDA Scales Up COVID-19 Vaccine Manufacturing Capacity With $628m For Emergent BioSolutions

 
• By Bowman Cox
Pharmaceutical manufacturer of vaccines, discovery of the right drug to fight a disease. Vaccine, protection campaign, health. Diseases and cures. 3d rendering. Immunity against diseases
Vaccine capacity secured at warp speed • Source: Shutterstock

More from Vaccines

More from Pink Sheet